{"id":"prednison","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Hypertension or aggravation of hypertension","drugRate":"","severity":"common","organSystem":""},{"effect":"Edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Increased appetite and weight gain","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Fluid retention","drugRate":"","severity":"common","organSystem":""},{"effect":"Acne","drugRate":"","severity":"common","organSystem":""},{"effect":"Insomnia","drugRate":"","severity":"common","organSystem":""},{"effect":"Mood changes","drugRate":"","severity":"common","organSystem":""},{"effect":"Increased sweating","drugRate":"","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"","severity":"common","organSystem":""},{"effect":"Nervousness","drugRate":"","severity":"common","organSystem":""},{"effect":"Restlessness","drugRate":"","severity":"common","organSystem":""},{"effect":"Hirsutism","drugRate":"","severity":"common","organSystem":""},{"effect":"Facial edema","drugRate":"","severity":"common","organSystem":""},{"effect":"Moon face","drugRate":"","severity":"common","organSystem":""},{"effect":"Buffalo hump","drugRate":"","severity":"common","organSystem":""},{"effect":"Thin fragile skin","drugRate":"","severity":"common","organSystem":""},{"effect":"Ecchymoses and petechiae","drugRate":"","severity":"common","organSystem":""},{"effect":"Muscle weakness","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Anastomosis of intestine","Arginase deficiency","Arginosuccinate Lyase Deficiency","Avascular necrosis of bone","Bilateral cataracts","Cerebral malaria","Cerebral trauma","Chronic heart failure","Cirrhosis of liver","Citrullinemia","Congenital hyperammonemia, type I","Diabetes mellitus","Disorder of muscle","Diverticulitis of gastrointestinal tract","Edema","Exposure to varicella","Gastritis","Herpes simplex","Hypercholesterolemia","Hyperglycemia","Hypertensive disorder","Hypokalemia","Hypopituitarism","Hypothyroidism","Immunosuppression","Inactive tuberculosis","Infection by Strongyloides","Infectious disease","Measles","Muscle atrophy","Mycosis","Open-angle glaucoma","Ophthalmic herpes simplex","Ornithine Carbamyltransferase Deficiency","Osteopenia","Osteoporosis","Pathological fracture","Peptic ulcer","Pregnancy, function","Psychotic disorder","Seizure disorder","Traumatic rupture of tendon","Tuberculosis","Varicella-zoster virus infection"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Anaphylaxis","drugRate":"","severity":"serious"},{"effect":"Cardiac arrest","drugRate":"","severity":"serious"},{"effect":"Circulatory collapse","drugRate":"","severity":"serious"},{"effect":"Myocardial rupture following recent myocardial infarction","drugRate":"","severity":"serious"},{"effect":"Peptic ulcer with possible perforation and hemorrhage","drugRate":"","severity":"serious"},{"effect":"Perforation of the small and large intestine","drugRate":"","severity":"serious"},{"effect":"Pancreatitis","drugRate":"","severity":"serious"},{"effect":"Adrenal insufficiency","drugRate":"","severity":"serious"},{"effect":"Aseptic necrosis of femoral and humeral heads","drugRate":"","severity":"serious"},{"effect":"Tendon rupture","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":{"chemblId":"CHEMBL15720","moleculeType":"Small molecule","molecularWeight":"358.43"},"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=prednison","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:39:10.381859+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:39:16.792968+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=prednison","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:39:17.881069+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL15720/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:39:18.354967+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"14d50f54-410b-45b2-a639-31498ceaf854","title":"PREDNISONE TABLETS, USP, 10 MG (PREDNISONE) TABLET [PD-RX PHARMACEUTICALS, INC.]"},"ecosystem":[],"mechanism":{"target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor"},"_scrapedAt":"2026-03-28T06:22:38.004Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:39:20.556550+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Acquired thrombocytopenia","diseaseId":"acquired-thrombocytopenia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Acute lymphoid leukemia","diseaseId":"acute-lymphoid-leukemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Adrenal cortical hypofunction","diseaseId":"adrenal-cortical-hypofunction","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Adrenogenital disorder","diseaseId":"adrenogenital-disorder","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Allergic rhinitis","diseaseId":"allergic-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Angioedema","diseaseId":"angioedema","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Ankylosing spondylitis","diseaseId":"ankylosing-spondylitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Articular gout","diseaseId":"articular-gout","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Asthma","diseaseId":"asthma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Atopic dermatitis","diseaseId":"atopic-dermatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Autoimmune disease","diseaseId":"autoimmune-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Autoimmune hemolytic anemia","diseaseId":"autoimmune-hemolytic-anemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Berylliosis","diseaseId":"berylliosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Chronic lymphoid leukemia, disease","diseaseId":"chronic-lymphoid-leukemia-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Congenital hypoplastic anemia","diseaseId":"congenital-hypoplastic-anemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Contact dermatitis","diseaseId":"contact-dermatitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Crohn's disease","diseaseId":"crohn's-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Dermatitis herpetiformis","diseaseId":"dermatitis-herpetiformis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Diffuse Proliferative Lupus Nephritis","diseaseId":"diffuse-proliferative-lupus-nephritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Diffuse non-Hodgkin's lymphoma, large cell","diseaseId":"diffuse-non-hodgkin's-lymphoma-large-cell","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Disorder of musculoskeletal system","diseaseId":"disorder-of-musculoskeletal-system","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Disorder of skin","diseaseId":"disorder-of-skin","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Edema of larynx","diseaseId":"edema-of-larynx","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Epicondylitis","diseaseId":"epicondylitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Erythema multiforme","diseaseId":"erythema-multiforme","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Erythroblastic Anemia","diseaseId":"erythroblastic-anemia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Erythroderma","diseaseId":"erythroderma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Exacerbation of asthma","diseaseId":"exacerbation-of-asthma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Follicular non-Hodgkin's lymphoma","diseaseId":"follicular-non-hodgkin's-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hodgkin's disease","diseaseId":"hodgkin's-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Humoral hypercalcemia of malignancy","diseaseId":"humoral-hypercalcemia-of-malignancy","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Idiopathic thrombocytopenic purpura","diseaseId":"idiopathic-thrombocytopenic-purpura","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection by larvae of Trichinella spiralis","diseaseId":"infection-by-larvae-of-trichinella-spiralis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Inflammatory bowel disease","diseaseId":"inflammatory-bowel-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Juvenile rheumatoid arthritis","diseaseId":"juvenile-rheumatoid-arthritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Löffler's syndrome","diseaseId":"löffler's-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Multiple sclerosis","diseaseId":"multiple-sclerosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Mycosis fungoides","diseaseId":"mycosis-fungoides","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nephrotic syndrome","diseaseId":"nephrotic-syndrome","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Non-Hodgkin's lymphoma","diseaseId":"non-hodgkin's-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pemphigus","diseaseId":"pemphigus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Prevention of Transplant Rejection","diseaseId":"prevention-of-transplant-rejection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Primary adrenocortical insufficiency","diseaseId":"primary-adrenocortical-insufficiency","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Primary cutaneous T-cell lymphoma","diseaseId":"primary-cutaneous-t-cell-lymphoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Psoriasis","diseaseId":"psoriasis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Psoriasis with arthropathy","diseaseId":"psoriasis-with-arthropathy","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Rheumatic heart disease","diseaseId":"rheumatic-heart-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Rheumatoid arthritis","diseaseId":"rheumatoid-arthritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Sarcoidosis","diseaseId":"sarcoidosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Systemic Dermatomyositis","diseaseId":"systemic-dermatomyositis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Systemic lupus erythematosus","diseaseId":"systemic-lupus-erythematosus","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Thyroiditis","diseaseId":"thyroiditis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Transfusion reaction due to serum protein reaction","diseaseId":"transfusion-reaction-due-to-serum-protein-reaction","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Transplanted organ rejection","diseaseId":"transplanted-organ-rejection","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02776436","phase":"PHASE1","title":"Reducing Dexamethasone Around Docetaxel Infusion","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2016-01","conditions":"Breast Cancer, Prostate Cancer","enrollment":46},{"nctId":"NCT07032532","phase":"PHASE2","title":"Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23)","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-07","conditions":"Peripheral T Cell Lymphoma","enrollment":35},{"nctId":"NCT06663618","phase":"NA","title":"Short-term Glucocorticoid Combined with MMF for IgG4-RD","status":"RECRUITING","sponsor":"Wen Zhang","startDate":"2023-09-01","conditions":"IgG4-related Disease","enrollment":63},{"nctId":"NCT00991211","phase":"PHASE3","title":"Bendamustine Plus Rituximab Versus CHOP Plus Rituximab","status":"COMPLETED","sponsor":"University of Giessen","startDate":"2004-01","conditions":"Non-Hodgkin Lymphomas, Follicular Lymphomas, Immunocytomas","enrollment":549},{"nctId":"NCT04232449","phase":"PHASE3","title":"Oral Corticosteroids for Post-infectious Cough in Adults","status":"TERMINATED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-11-06","conditions":"Post-infectious Cough","enrollment":32},{"nctId":"NCT05234684","phase":"PHASE3","title":"A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma","status":"UNKNOWN","sponsor":"Beijing InnoCare Pharma Tech Co., Ltd.","startDate":"2022-11-02","conditions":"Diffuse Large B Cell Lymphoma (DLBCL)","enrollment":150},{"nctId":"NCT05933967","phase":"PHASE2","title":"A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma","status":"RECRUITING","sponsor":"Shandong Cancer Hospital and Institute","startDate":"2023-06-01","conditions":"The First Affiliated Hospital of Nanchang University","enrollment":31},{"nctId":"NCT04036721","phase":"PHASE4","title":"Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis","status":"SUSPENDED","sponsor":"National Institute for Tuberculosis and Lung Diseases, Poland","startDate":"2019-10-01","conditions":"Lung Neoplasm Malignant, Interstitial Lung Disease","enrollment":85},{"nctId":"NCT05498259","phase":"PHASE2","title":"Orelabrutinib With R-CHOP-like Regimen for Patients With Newly Diagnosed Untreated Non-GCB DLBCL","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-07-27","conditions":"Diffuse Large B-Cell Lymphoma","enrollment":46},{"nctId":"NCT02042391","phase":"PHASE2","title":"Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy","status":"COMPLETED","sponsor":"Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH","startDate":"2015-02-03","conditions":"Posttransplant Lymphoproliferative Disorder","enrollment":60},{"nctId":"NCT01958190","phase":"PHASE4","title":"Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus","status":"COMPLETED","sponsor":"Foundation for Liver Research","startDate":"2011-02-07","conditions":"Liver Disease","enrollment":196},{"nctId":"NCT04424862","phase":"PHASE4","title":"Multitarget Therapy for Idiopathic Membranous Nephropathy","status":"COMPLETED","sponsor":"Beijing Friendship Hospital","startDate":"2020-06-09","conditions":"Efficacy","enrollment":82},{"nctId":"NCT05238064","phase":"PHASE1, PHASE2","title":"Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2022-03","conditions":"PI3Kδ Inhibitor, Parsaclisib, CHOP","enrollment":30},{"nctId":"NCT04659915","phase":"PHASE4","title":"Counteracting Deleterious Metabolic Glucocorticoid Effects With Metformin","status":"COMPLETED","sponsor":"Eleonora Seelig","startDate":"2021-02-25","conditions":"Glucocorticoid Effect","enrollment":19},{"nctId":"NCT05006664","phase":"PHASE2","title":"Brentuximab Vedotin in Combination With CHEP in Patient With PTCL","status":"UNKNOWN","sponsor":"Czech Lymphoma Study Group","startDate":"2021-10","conditions":"Lymphoma, T-Cell, Peripheral","enrollment":33},{"nctId":"NCT00053768","phase":"PHASE3","title":"Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"German High-Grade Non-Hodgkin's Lymphoma Study Group","startDate":"2002-04","conditions":"Lymphoma","enrollment":392},{"nctId":"NCT02237261","phase":"PHASE2","title":"Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma","status":"COMPLETED","sponsor":"University Hospital Heidelberg","startDate":"2014-11","conditions":"Multiple Myeloma","enrollment":46},{"nctId":"NCT04409691","phase":"PHASE1","title":"SCMC Trial on KHE With KMP (V.2020)","status":"UNKNOWN","sponsor":"Shanghai Children's Medical Center","startDate":"2020-07-01","conditions":"Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)","enrollment":20},{"nctId":"NCT00657059","phase":"PHASE3","title":"Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2007-09","conditions":"IgA Nephropathy","enrollment":151},{"nctId":"NCT02526823","phase":"PHASE4","title":"Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2015-08","conditions":"Lymphoma, Non-Hodgkin;Hodgkin Disease","enrollment":360},{"nctId":"NCT00646854","phase":"PHASE3","title":"Alemtuzumab and CHOP in T-cell Lymphoma","status":"COMPLETED","sponsor":"Aarhus University Hospital","startDate":"2008-06","conditions":"Lymphoma, T-Cell, Peripheral","enrollment":136},{"nctId":"NCT03356912","phase":"PHASE2","title":"CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy","status":"UNKNOWN","sponsor":"Consorzio Oncotech","startDate":"2017-11-22","conditions":"Prostate Cancer, Castration-resistant Prostate Cancer","enrollment":220},{"nctId":"NCT02595242","phase":"PHASE1","title":"Safety and Efficacy Study of CNOP Chemotherapy in Diffuse Large B Cell Lymphoma","status":"WITHDRAWN","sponsor":"CSPC ZhongQi Pharmaceutical Technology Co., Ltd.","startDate":"2015-06","conditions":"Diffuse Large B Cell Lymphoma","enrollment":""},{"nctId":"NCT02543073","phase":"PHASE1, PHASE2","title":"MSC for Treatment of Interstitial Lung Disease After Allo-HSCT","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2014-09","conditions":"Lung Diseases, Interstitial, Hematopoietic Stem Cell Transplantation, Bronchiolitis Obliterans","enrollment":60},{"nctId":"NCT02487316","phase":"PHASE4","title":"A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib","status":"WITHDRAWN","sponsor":"Jun Zhu","startDate":"2015-07","conditions":"Systemic Anaplastic Large-Cell Lymphoma","enrollment":""},{"nctId":"NCT02996617","phase":"PHASE4","title":"PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2016-11","conditions":"Lymphoma,Non-Hodgkin","enrollment":240},{"nctId":"NCT01023815","phase":"PHASE3","title":"Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.","status":"COMPLETED","sponsor":"Novartis","startDate":"2009-04","conditions":"de Novo Kidney Transplant Recipients, Renal Transplantation","enrollment":330},{"nctId":"NCT00651040","phase":"PHASE3","title":"Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM","status":"COMPLETED","sponsor":"Institute of Rheumatology, Prague","startDate":"2008-05","conditions":"Polymyositis, Dermatomyositis","enrollment":31},{"nctId":"NCT01352338","phase":"PHASE1, PHASE2","title":"Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2011-08","conditions":"Multiple Myeloma","enrollment":82},{"nctId":"NCT02155374","phase":"PHASE4","title":"Glucose Control for Glucocorticoid Induced Hyperglycemia During Chemotherapy","status":"COMPLETED","sponsor":"Slotervaart Hospital","startDate":"2014-05","conditions":"Hyperglycemia Steroid-induced","enrollment":26},{"nctId":"NCT01411514","phase":"PHASE4","title":"Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis","status":"TERMINATED","sponsor":"Claudio Gobbi","startDate":"2011-08","conditions":"Multiple Sclerosis","enrollment":27},{"nctId":"NCT00908089","phase":"PHASE4","title":"TNF-blocking Therapy in Combination With Disease-modifying Antirheumatic Drugs in Early Rheumatoid Arthritis","status":"UNKNOWN","sponsor":"University of Helsinki","startDate":"2003-03","conditions":"Rheumatoid Arthritis","enrollment":100},{"nctId":"NCT01299922","phase":"PHASE3","title":"Clinical Trial Treatment in Lupus Nephritis","status":"WITHDRAWN","sponsor":"Hospital Universitario Fundación Alcorcón","startDate":"2011-02","conditions":"Lupus Nephritis","enrollment":""},{"nctId":"NCT01502982","phase":"PHASE2","title":"Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)","status":"COMPLETED","sponsor":"Nordic Lymphoma Group","startDate":"2004-11","conditions":"Diffuse Large B-Cell Lymphoma","enrollment":160},{"nctId":"NCT00450970","phase":"PHASE3","title":"Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)","status":"TERMINATED","sponsor":"Agennix","startDate":"2007-02","conditions":"Prostate Cancer","enrollment":344},{"nctId":"NCT00721552","phase":"NA","title":"Sitagliptin Prophylaxis for Glucocorticoid-Induced Impairment of Glucose Metabolism in Males With the Metabolic Syndrome","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2008-10","conditions":"Diabetes Mellitus, Steroid Diabetes, Glucocorticoid-induced Diabetes","enrollment":82},{"nctId":"NCT01469702","phase":"PHASE4","title":"The Efficacy of Prednisone and Azithromycin in the Treatment of Patients With Cat Scratch Disease","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2011-12","conditions":"Cat-scratch Disease, Bartonella Infections","enrollment":10},{"nctId":"NCT00135122","phase":"PHASE3","title":"Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache","status":"COMPLETED","sponsor":"Sorlandet Hospital HF","startDate":"2003-09","conditions":"Headache","enrollment":100},{"nctId":"NCT00187161","phase":"PHASE2","title":"Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"1994-11","conditions":"Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Mature B-Cell","enrollment":68}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL15720"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":94,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"prednison","genericName":"prednison","companyName":"Wen Zhang","companyId":"wen-zhang","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:39:20.556550+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}